Skinvisible (SKVI) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) Interest Coverage Ratio Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.74% |
| Mar 31, 2026 | -21.08% |
| Dec 31, 2025 | -130.43% |
| Sep 30, 2025 | -12.54% |
| Jun 30, 2025 | -86.30% |
| Mar 31, 2025 | -17.99% |
| Dec 31, 2024 | -25.46% |
| Sep 30, 2024 | -10.66% |
| Jun 30, 2024 | -22.23% |
| Mar 31, 2024 | -0.37% |
| Dec 31, 2023 | -2.84% |
| Sep 30, 2023 | -29.37% |
| Jun 30, 2023 | -6.36% |
| Mar 31, 2023 | 31.76% |
| Dec 31, 2022 | -22.51% |
| Sep 30, 2022 | -4.84% |
| Jun 30, 2022 | 18.51% |
| Mar 31, 2022 | 10.36% |
| Dec 31, 2021 | 21.03% |
| Sep 30, 2021 | 48.19% |